Correlation Between Fisher Paykel and Richmond Vanadium

Can any of the company-specific risk be diversified away by investing in both Fisher Paykel and Richmond Vanadium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fisher Paykel and Richmond Vanadium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fisher Paykel Healthcare and Richmond Vanadium Technology, you can compare the effects of market volatilities on Fisher Paykel and Richmond Vanadium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fisher Paykel with a short position of Richmond Vanadium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fisher Paykel and Richmond Vanadium.

Diversification Opportunities for Fisher Paykel and Richmond Vanadium

-0.7

Correlation Coefficient

Fisher Paykel  Richmond Vanadium

Excellent diversification

The 3 months correlation between Fisher and Richmond is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Fisher Paykel Healthcare and Richmond Vanadium Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Richmond Vanadium and Fisher Paykel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fisher Paykel Healthcare are associated (or correlated) with Richmond Vanadium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Richmond Vanadium has no effect on the direction of Fisher Paykel i.e., Fisher Paykel and Richmond Vanadium go up and down completely randomly.

Pair Corralation between Fisher Paykel and Richmond Vanadium

Assuming the 90 days trading horizon Fisher Paykel is expected to generate 1.18 times less return on investment than Richmond Vanadium. But when comparing it to its historical volatility, Fisher Paykel Healthcare is 3.31 times less risky than Richmond Vanadium. It trades about 0.07 of its potential returns per unit of risk. Richmond Vanadium Technology is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  23.00  in Richmond Vanadium Technology on October 5, 2024 and sell it today you would lose (1.00) from holding Richmond Vanadium Technology or give up 4.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Fisher Paykel Healthcare  vs.  Richmond Vanadium Technology

Fisher Paykel Healthcare

Risk-Adjusted Performance

10 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fisher Paykel Healthcare are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical indicators, Fisher Paykel may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Richmond Vanadium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Richmond Vanadium Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Fisher Paykel and Richmond Vanadium

The main advantage of trading using opposite Fisher Paykel and Richmond Vanadium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fisher Paykel position performs unexpectedly, Richmond Vanadium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Richmond Vanadium will offset losses from the drop in Richmond Vanadium's long position.

The idea behind Fisher Paykel Healthcare and Richmond Vanadium Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.